The U.S. Food & Drug Administration declined to approve two China-tested cancer treatments on Monday, raising concerns over the future of drugs tested in...
Antibe Therapeutics Inc., a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation announced to sell its...
SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19vaccine candidate adjuvanted with GSK’s pandemic...
Tirzepatide achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli Lilly and Company's SURMOUNT-1 clinical trial,...
Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated continent frustrated by sluggish Western handouts, risks shutting down after...